| 1 | [SID74373446] | Active | AC50 | 4.34 | Luminescence Cell-Based Dose Retest to Confirm Inhibitors of Beta Cell Apoptosis [AID449756, Type: confirmatory] | |  View X | Row No. | 1 | | Structure |
| | Substance | | | SID | 74373446 | | CID | 53299545 | | Outcome | Active | | AC50 | 4.34 [uM] | | BioAssay | Luminescence Cell-Based Dose Retest to Confirm Inhibitors of Beta Cell Apoptosis | | AID | 449756 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 2 | [SID74373446] | Active | AC50 | 4.437 | ATP-based Luminescence in the Absence of Cytokines Measured in Cell-Based System Using Plate Reader - 2061-06_Inhibitor_Dose_CherryPick [AID463229, Type: confirmatory] | |  View X | Row No. | 2 | | Structure |
| | Substance | | | SID | 74373446 | | CID | 53299545 | | Outcome | Active | | AC50 | 4.437 [uM] | | BioAssay | ATP-based Luminescence in the Absence of Cytokines Measured in Cell-Based System Using Plate Reader - 2061-06_Inhibitor_Dose_CherryPick | | AID | 463229 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 3 | [SID74373446] | Active | AC50 | 6.783 | Dose Response HTS Screen to Identify Cytotoxic Compounds of HMLE_sh_eGFP [AID463074, Type: confirmatory] | |  View X | Row No. | 3 | | Structure |
| | Substance | | | SID | 74373446 | | CID | 53299545 | | Outcome | Active | | AC50 | 6.783 [uM] | | BioAssay | Dose Response HTS Screen to Identify Cytotoxic Compounds of HMLE_sh_eGFP | | AID | 463074 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 4 | [SID74373446] | Active | AC50 | 6.871 | Luminescence Cell-Based Dose Retest to Confirm Inhibitors of Cancer Stem Cells [AID449748, Type: confirmatory] | |  View X | Row No. | 4 | | Structure |
| | Substance | | | SID | 74373446 | | CID | 53299545 | | Outcome | Active | | AC50 | 6.871 [uM] | | BioAssay | Luminescence Cell-Based Dose Retest to Confirm Inhibitors of Cancer Stem Cells | | AID | 449748 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 5 | [SID74373446] | Active | Potency | 7.3048 | qHTS screen for small molecules that inhibit ELG1-dependent DNA repair in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1 [AID504467, Type: confirmatory] | ATAD5 protein [Homo sapiens] [gi:116283940] |  View X | Row No. | 5 | | Structure |
| | Substance | | | SID | 74373446 | | CID | 53299545 | | Outcome | Active | | Potency | 7.3048 [uM] | | BioAssay | qHTS screen for small molecules that inhibit ELG1-dependent DNA repair in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1 | | AID | 504467 | | BioAssay type | confirmatory | | Target | ATAD5 protein [Homo sapiens] [gi:116283940] | | PubMed | | | Data Table |  |
|
| 6 | [SID124753353] | Active | Potency | 11.2202 | qHTS for Inhibitors of ATXN expression [AID651635, Type: confirmatory] | ATXN2 gene product [Homo sapiens] [gi:171543895] |  View X | Row No. | 6 | | Structure |
| | Substance | | | SID | 124753353 | | CID | 53299545 | | Outcome | Active | | Potency | 11.2202 [uM] | | BioAssay | qHTS for Inhibitors of ATXN expression | | AID | 651635 | | BioAssay type | confirmatory | | Target | ATXN2 gene product [Homo sapiens] [gi:171543895] | | PubMed | | | Data Table |  |
|
| 7 | [SID74373446] | Active | Potency | 12.5893 | qHTS for Inhibitors of TGF-b [AID588855, Type: confirmatory] | Smad3 [Homo sapiens] [gi:18418623] |  View X | Row No. | 7 | | Structure |
| | Substance | | | SID | 74373446 | | CID | 53299545 | | Outcome | Active | | Potency | 12.5893 [uM] | | BioAssay | qHTS for Inhibitors of TGF-b | | AID | 588855 | | BioAssay type | confirmatory | | Target | Smad3 [Homo sapiens] [gi:18418623] | | PubMed | | | Data Table |  |
|
| 8 | [SID74373446] | Active | Potency | 12.5893 | qHTS for Inhibitors of TGF-b [AID588855, Type: confirmatory] | Smad3 [Homo sapiens] [gi:18418623] |  View X | Row No. | 8 | | Structure |
| | Substance | | | SID | 74373446 | | CID | 53299545 | | Outcome | Active | | Potency | 12.5893 [uM] | | BioAssay | qHTS for Inhibitors of TGF-b | | AID | 588855 | | BioAssay type | confirmatory | | Target | Smad3 [Homo sapiens] [gi:18418623] | | PubMed | | | Data Table |  |
|
| 9 | [SID74373446] | Active | Potency | 14.1254 | qHTS for Inhibitors of TGF-b: Cytotox Counterscreen [AID588856, Type: confirmatory] | |  View X | Row No. | 9 | | Structure |
| | Substance | | | SID | 74373446 | | CID | 53299545 | | Outcome | Active | | Potency | 14.1254 [uM] | | BioAssay | qHTS for Inhibitors of TGF-b: Cytotox Counterscreen | | AID | 588856 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 10 | [SID74373446] | Active | EC50 | 15.4 | Dose Response confirmation of Image-Based HTS for Selective Agonists for NTR1 [AID504549, Type: confirmatory] | NTSR1 gene product [Homo sapiens] [gi:110611243] |  View X | Row No. | 10 | | Structure |
| | Substance | | | SID | 74373446 | | CID | 53299545 | | Outcome | Active | | EC50 | 15.4 [uM] | | BioAssay | Dose Response confirmation of Image-Based HTS for Selective Agonists for NTR1 | | AID | 504549 | | BioAssay type | confirmatory | | Target | NTSR1 gene product [Homo sapiens] [gi:110611243] | | PubMed | | | Data Table |  |
|
| 11 | [SID74373446] | Active | EC50 | 15.4 | Dose Response confirmation of Image-Based HTS for Selective Agonists for NTR1 [AID504549, Type: confirmatory] | NTSR1 gene product [Homo sapiens] [gi:110611243] |  View X | Row No. | 11 | | Structure |
| | Substance | | | SID | 74373446 | | CID | 53299545 | | Outcome | Active | | EC50 | 15.4 [uM] | | BioAssay | Dose Response confirmation of Image-Based HTS for Selective Agonists for NTR1 | | AID | 504549 | | BioAssay type | confirmatory | | Target | NTSR1 gene product [Homo sapiens] [gi:110611243] | | PubMed | | | Data Table |  |
|
| 12 | [SID124753353] | Active | Potency | 18.3564 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT [AID686979, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 12 | | Structure |
| | Substance | | | SID | 124753353 | | CID | 53299545 | | Outcome | Active | | Potency | 18.3564 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT | | AID | 686979 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 13 | [SID124753353] | Active | Potency | 18.3564 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT [AID686979, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 13 | | Structure |
| | Substance | | | SID | 124753353 | | CID | 53299545 | | Outcome | Active | | Potency | 18.3564 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT | | AID | 686979 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 14 | [SID124753353] | Active | Potency | 18.3564 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT [AID686979, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 14 | | Structure |
| | Substance | | | SID | 124753353 | | CID | 53299545 | | Outcome | Active | | Potency | 18.3564 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT | | AID | 686979 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 15 | [SID74373446] | Active | Potency | 18.3564 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT [AID686978, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 15 | | Structure |
| | Substance | | | SID | 74373446 | | CID | 53299545 | | Outcome | Active | | Potency | 18.3564 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT | | AID | 686978 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 16 | [SID74373446] | Active | Potency | 18.3564 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT [AID686978, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 16 | | Structure |
| | Substance | | | SID | 74373446 | | CID | 53299545 | | Outcome | Active | | Potency | 18.3564 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT | | AID | 686978 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 17 | [SID74373446] | Active | Potency | 18.3564 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT [AID686978, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 17 | | Structure |
| | Substance | | | SID | 74373446 | | CID | 53299545 | | Outcome | Active | | Potency | 18.3564 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT | | AID | 686978 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 18 | [SID74373446] | Active | Potency | 20.5962 | qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-NT fibrosarcoma cell line [AID686970, Type: confirmatory] | IDH1 [Homo sapiens] [gi:49168486] |  View X | Row No. | 18 | | Structure |
| | Substance | | | SID | 74373446 | | CID | 53299545 | | Outcome | Active | | Potency | 20.5962 [uM] | | BioAssay | qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-NT fibrosarcoma cell line | | AID | 686970 | | BioAssay type | confirmatory | | Target | IDH1 [Homo sapiens] [gi:49168486] | | PubMed | | | Data Table |  |
|
| 19 | [SID74373446] | Active | Potency | 20.5962 | qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-NT fibrosarcoma cell line [AID686970, Type: confirmatory] | IDH1 [Homo sapiens] [gi:49168486] |  View X | Row No. | 19 | | Structure |
| | Substance | | | SID | 74373446 | | CID | 53299545 | | Outcome | Active | | Potency | 20.5962 [uM] | | BioAssay | qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-NT fibrosarcoma cell line | | AID | 686970 | | BioAssay type | confirmatory | | Target | IDH1 [Homo sapiens] [gi:49168486] | | PubMed | | | Data Table |  |
|
| 20 | [SID74373446] | Active | Potency | 20.5962 | qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-NT fibrosarcoma cell line [AID686970, Type: confirmatory] | IDH1 [Homo sapiens] [gi:49168486] |  View X | Row No. | 20 | | Structure |
| | Substance | | | SID | 74373446 | | CID | 53299545 | | Outcome | Active | | Potency | 20.5962 [uM] | | BioAssay | qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-NT fibrosarcoma cell line | | AID | 686970 | | BioAssay type | confirmatory | | Target | IDH1 [Homo sapiens] [gi:49168486] | | PubMed | | | Data Table |  |
|
| 21 | [SID74373446] | Active | Potency | 28.1838 | qHTS for Antagonists of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS [AID624288, Type: confirmatory] | Guanine nucleotide-binding protein G(s) subunit alpha isoforms short [gi:52000961] |  View X | Row No. | 21 | | Structure |
| | Substance | | | SID | 74373446 | | CID | 53299545 | | Outcome | Active | | Potency | 28.1838 [uM] | | BioAssay | qHTS for Antagonists of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS | | AID | 624288 | | BioAssay type | confirmatory | | Target | Guanine nucleotide-binding protein G(s) subunit alpha isoforms short [gi:52000961] | | PubMed | | | Data Table |  |
|
| 22 | [SID74373446] | Active | | | Counterscreen for inhibitors of the fructose-bisphosphate aldolase (FBA) of M. tuberculosis: Fluroescence-based biochemical high throughput Glycerophosphate Dehydrogenase-Triosephosphate Isomerase (GDH-TPI) assay to identify assay artifacts [AID652141, Type: screening] | |  View X | Row No. | 22 | | Structure |
| | Substance | | | SID | 74373446 | | CID | 53299545 | | Outcome | Active | | BioAssay | Counterscreen for inhibitors of the fructose-bisphosphate aldolase (FBA) of M. tuberculosis: Fluroescence-based biochemical high throughput Glycerophosphate Dehydrogenase-Triosephosphate Isomerase (GDH-TPI) assay to identify assay artifacts | | AID | 652141 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 23 | [SID74373446] | Active | | | uHTS for identification of Inhibitors of Mdm2/MdmX interaction in luminescent format. [AID485346, Type: screening] | protein Mdm4 isoform 1 [Homo sapiens] [gi:88702791] |  View X | Row No. | 23 | | Structure |
| | Substance | | | SID | 74373446 | | CID | 53299545 | | Outcome | Active | | BioAssay | uHTS for identification of Inhibitors of Mdm2/MdmX interaction in luminescent format. | | AID | 485346 | | BioAssay type | screening | | Target | protein Mdm4 isoform 1 [Homo sapiens] [gi:88702791] | | PubMed | | | Data Table |  |
|
| 24 | [SID74373446] | Active | | | uHTS for identification of Inhibitors of Mdm2/MdmX interaction in luminescent format. [AID485346, Type: screening] | protein Mdm4 isoform 1 [Homo sapiens] [gi:88702791] |  View X | Row No. | 24 | | Structure |
| | Substance | | | SID | 74373446 | | CID | 53299545 | | Outcome | Active | | BioAssay | uHTS for identification of Inhibitors of Mdm2/MdmX interaction in luminescent format. | | AID | 485346 | | BioAssay type | screening | | Target | protein Mdm4 isoform 1 [Homo sapiens] [gi:88702791] | | PubMed | | | Data Table |  |
|
| 25 | [SID74373446] | Active | | | Single concentration confirmation of Image-Based HTS for Selective Agonists for NTR1 [AID504550, Type: screening] | NTSR1 gene product [Homo sapiens] [gi:110611243] |  View X | Row No. | 25 | | Structure |
| | Substance | | | SID | 74373446 | | CID | 53299545 | | Outcome | Active | | BioAssay | Single concentration confirmation of Image-Based HTS for Selective Agonists for NTR1 | | AID | 504550 | | BioAssay type | screening | | Target | NTSR1 gene product [Homo sapiens] [gi:110611243] | | PubMed | | | Data Table |  |
|
| 26 | [SID74373446] | Active | | | Single concentration confirmation of Image-Based HTS for Selective Agonists for NTR1 [AID504550, Type: screening] | NTSR1 gene product [Homo sapiens] [gi:110611243] |  View X | Row No. | 26 | | Structure |
| | Substance | | | SID | 74373446 | | CID | 53299545 | | Outcome | Active | | BioAssay | Single concentration confirmation of Image-Based HTS for Selective Agonists for NTR1 | | AID | 504550 | | BioAssay type | screening | | Target | NTSR1 gene product [Homo sapiens] [gi:110611243] | | PubMed | | | Data Table |  |
|
| 27 | [SID74373446] | Active | | | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human M1 muscarinic receptor (CHRM1) [AID588852, Type: screening] | CHRM1 gene product [Homo sapiens] [gi:37622910] |  View X | Row No. | 27 | | Structure |
| | Substance | | | SID | 74373446 | | CID | 53299545 | | Outcome | Active | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human M1 muscarinic receptor (CHRM1) | | AID | 588852 | | BioAssay type | screening | | Target | CHRM1 gene product [Homo sapiens] [gi:37622910] | | PubMed | | | Data Table |  |
|
| 28 | [SID74373446] | Active | | | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human M1 muscarinic receptor (CHRM1) [AID588852, Type: screening] | CHRM1 gene product [Homo sapiens] [gi:37622910] |  View X | Row No. | 28 | | Structure |
| | Substance | | | SID | 74373446 | | CID | 53299545 | | Outcome | Active | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human M1 muscarinic receptor (CHRM1) | | AID | 588852 | | BioAssay type | screening | | Target | CHRM1 gene product [Homo sapiens] [gi:37622910] | | PubMed | | | Data Table |  |
|
| 29 | [SID74373446] | Active | | | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the orexin 1 receptor (OX1R; HCRTR1) [AID434989, Type: screening] | orexin receptor type 1 [Homo sapiens] [gi:222080095] |  View X | Row No. | 29 | | Structure |
| | Substance | | | SID | 74373446 | | CID | 53299545 | | Outcome | Active | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the orexin 1 receptor (OX1R; HCRTR1) | | AID | 434989 | | BioAssay type | screening | | Target | orexin receptor type 1 [Homo sapiens] [gi:222080095] | | PubMed | | | Data Table |  |
|
| 30 | [SID74373446] | Active | | | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the orexin 1 receptor (OX1R; HCRTR1) [AID434989, Type: screening] | orexin receptor type 1 [Homo sapiens] [gi:222080095] |  View X | Row No. | 30 | | Structure |
| | Substance | | | SID | 74373446 | | CID | 53299545 | | Outcome | Active | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the orexin 1 receptor (OX1R; HCRTR1) | | AID | 434989 | | BioAssay type | screening | | Target | orexin receptor type 1 [Homo sapiens] [gi:222080095] | | PubMed | | | Data Table |  |
|
| 31 | [SID74373446] | Active | | | FRET-based cell-based primary high throughput screening assay to identify antagonists of the orexin 1 receptor (OX1R; HCRTR1) [AID485270, Type: screening] | orexin receptor type 1 [Homo sapiens] [gi:222080095] |  View X | Row No. | 31 | | Structure |
| | Substance | | | SID | 74373446 | | CID | 53299545 | | Outcome | Active | | BioAssay | FRET-based cell-based primary high throughput screening assay to identify antagonists of the orexin 1 receptor (OX1R; HCRTR1) | | AID | 485270 | | BioAssay type | screening | | Target | orexin receptor type 1 [Homo sapiens] [gi:222080095] | | PubMed | | | Data Table |  |
|
| 32 | [SID74373446] | Active | | | FRET-based cell-based primary high throughput screening assay to identify antagonists of the orexin 1 receptor (OX1R; HCRTR1) [AID485270, Type: screening] | orexin receptor type 1 [Homo sapiens] [gi:222080095] |  View X | Row No. | 32 | | Structure |
| | Substance | | | SID | 74373446 | | CID | 53299545 | | Outcome | Active | | BioAssay | FRET-based cell-based primary high throughput screening assay to identify antagonists of the orexin 1 receptor (OX1R; HCRTR1) | | AID | 485270 | | BioAssay type | screening | | Target | orexin receptor type 1 [Homo sapiens] [gi:222080095] | | PubMed | | | Data Table |  |
|
| 33 | [SID74373446] | Active | | | uHTS identification of small molecule inhibitors of the mitochondrial permeability transition pore via an absorbance assay [AID602449, Type: screening] | |  View X | Row No. | 33 | | Structure |
| | Substance | | | SID | 74373446 | | CID | 53299545 | | Outcome | Active | | BioAssay | uHTS identification of small molecule inhibitors of the mitochondrial permeability transition pore via an absorbance assay | | AID | 602449 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 34 | [SID74373446] | Active | | | Fluorescence-based counterscreen for orexin 1 receptor (OX1R) antagonists: cell-based assay to identify antagonists of the parental CHO cell line [AID463079, Type: screening] | |  View X | Row No. | 34 | | Structure |
| | Substance | | | SID | 74373446 | | CID | 53299545 | | Outcome | Active | | BioAssay | Fluorescence-based counterscreen for orexin 1 receptor (OX1R) antagonists: cell-based assay to identify antagonists of the parental CHO cell line | | AID | 463079 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 35 | [SID74373446] | Active | | | Single concentration confirmation of uHTS inhibitor hits of the mitochondrial permeability transition pore via a fluorescent based assay [AID624504, Type: screening] | |  View X | Row No. | 35 | | Structure |
| | Substance | | | SID | 74373446 | | CID | 53299545 | | Outcome | Active | | BioAssay | Single concentration confirmation of uHTS inhibitor hits of the mitochondrial permeability transition pore via a fluorescent based assay | | AID | 624504 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 36 | [SID74373446] | Active | | | Counterscreen for biased ligands (antagonists) of the melanocortin 4 receptor (MC4R): TRFRET-based cell-based high throughput assay to identify nonselective inhibitors of cAMP signaling [AID602193, Type: screening] | |  View X | Row No. | 36 | | Structure |
| | Substance | | | SID | 74373446 | | CID | 53299545 | | Outcome | Active | | BioAssay | Counterscreen for biased ligands (antagonists) of the melanocortin 4 receptor (MC4R): TRFRET-based cell-based high throughput assay to identify nonselective inhibitors of cAMP signaling | | AID | 602193 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 37 | [SID74373446] | Active | | | Luminescence Cell-Based Primary HTS to Identify Inhibitors of Beta Cell Apoptosis. [AID435005, Type: screening] | |  View X | Row No. | 37 | | Structure |
| | Substance | | | SID | 74373446 | | CID | 53299545 | | Outcome | Active | | BioAssay | Luminescence Cell-Based Primary HTS to Identify Inhibitors of Beta Cell Apoptosis. | | AID | 435005 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 38 | [SID74373446] | Active | | | Luminescence Cell-Based Primary HTS to Identify Inhibitors of Cancer Stem Cells [AID2717, Type: screening] | |  View X | Row No. | 38 | | Structure |
| | Substance | | | SID | 74373446 | | CID | 53299545 | | Outcome | Active | | BioAssay | Luminescence Cell-Based Primary HTS to Identify Inhibitors of Cancer Stem Cells | | AID | 2717 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 39 | [SID74373446] | Active | | | uHTS identification of small molecule agonists of the APJ receptor via a luminescent beta-arrestin assay [AID2520, Type: screening] | APLNR gene product [Homo sapiens] [gi:4885057] |  View X | Row No. | 39 | | Structure |
| | Substance | | | SID | 74373446 | | CID | 53299545 | | Outcome | Active | | BioAssay | uHTS identification of small molecule agonists of the APJ receptor via a luminescent beta-arrestin assay | | AID | 2520 | | BioAssay type | screening | | Target | APLNR gene product [Homo sapiens] [gi:4885057] | | PubMed | | | Data Table |  |
|
| 40 | [SID74373446] | Active | | | uHTS identification of small molecule agonists of the APJ receptor via a luminescent beta-arrestin assay [AID2520, Type: screening] | APLNR gene product [Homo sapiens] [gi:4885057] |  View X | Row No. | 40 | | Structure |
| | Substance | | | SID | 74373446 | | CID | 53299545 | | Outcome | Active | | BioAssay | uHTS identification of small molecule agonists of the APJ receptor via a luminescent beta-arrestin assay | | AID | 2520 | | BioAssay type | screening | | Target | APLNR gene product [Homo sapiens] [gi:4885057] | | PubMed | | | Data Table |  |
|
| 41 | [SID124753353] | Active | | | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human cholinergic receptor, muscarinic 4 (CHRM4) [AID624125, Type: screening] | CHRM4 gene product [Homo sapiens] [gi:52426748] |  View X | Row No. | 41 | | Structure |
| | Substance | | | SID | 124753353 | | CID | 53299545 | | Outcome | Active | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human cholinergic receptor, muscarinic 4 (CHRM4) | | AID | 624125 | | BioAssay type | screening | | Target | CHRM4 gene product [Homo sapiens] [gi:52426748] | | PubMed | | | Data Table |  |
|
| 42 | [SID124753353] | Active | | | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human cholinergic receptor, muscarinic 4 (CHRM4) [AID624125, Type: screening] | CHRM4 gene product [Homo sapiens] [gi:52426748] |  View X | Row No. | 42 | | Structure |
| | Substance | | | SID | 124753353 | | CID | 53299545 | | Outcome | Active | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human cholinergic receptor, muscarinic 4 (CHRM4) | | AID | 624125 | | BioAssay type | screening | | Target | CHRM4 gene product [Homo sapiens] [gi:52426748] | | PubMed | | | Data Table |  |
|
| 43 | [SID124753353] | Active | | | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human cholinergic receptor, muscarinic 4 (CHRM4) [AID624125, Type: screening] | CHRM4 gene product [Homo sapiens] [gi:52426748] |  View X | Row No. | 43 | | Structure |
| | Substance | | | SID | 124753353 | | CID | 53299545 | | Outcome | Active | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human cholinergic receptor, muscarinic 4 (CHRM4) | | AID | 624125 | | BioAssay type | screening | | Target | CHRM4 gene product [Homo sapiens] [gi:52426748] | | PubMed | | | Data Table |  |
|
| 44 | [SID74373446] | Active | | | TRFRET-based cell-based high throughput confirmation assay for biased ligands (antagonists) of the melanocortin 4 receptor (MC4R) [AID602195, Type: screening] | melanocortin receptor 4 [Homo sapiens] [gi:119508433] |  View X | Row No. | 44 | | Structure |
| | Substance | | | SID | 74373446 | | CID | 53299545 | | Outcome | Active | | BioAssay | TRFRET-based cell-based high throughput confirmation assay for biased ligands (antagonists) of the melanocortin 4 receptor (MC4R) | | AID | 602195 | | BioAssay type | screening | | Target | melanocortin receptor 4 [Homo sapiens] [gi:119508433] | | PubMed | | | Data Table |  |
|
| 45 | [SID74373446] | Active | | | TRFRET-based cell-based high throughput confirmation assay for biased ligands (antagonists) of the melanocortin 4 receptor (MC4R) [AID602195, Type: screening] | melanocortin receptor 4 [Homo sapiens] [gi:119508433] |  View X | Row No. | 45 | | Structure |
| | Substance | | | SID | 74373446 | | CID | 53299545 | | Outcome | Active | | BioAssay | TRFRET-based cell-based high throughput confirmation assay for biased ligands (antagonists) of the melanocortin 4 receptor (MC4R) | | AID | 602195 | | BioAssay type | screening | | Target | melanocortin receptor 4 [Homo sapiens] [gi:119508433] | | PubMed | | | Data Table |  |
|
| 46 | [SID74373446] | Active | | | TRFRET-based cell-based primary high throughput screening assay to identify biased ligands of the melanocortin 4 receptor (MC4R): antagonists of MC4R [AID540295, Type: screening] | melanocortin receptor 4 [Homo sapiens] [gi:119508433] |  View X | Row No. | 46 | | Structure |
| | Substance | | | SID | 74373446 | | CID | 53299545 | | Outcome | Active | | BioAssay | TRFRET-based cell-based primary high throughput screening assay to identify biased ligands of the melanocortin 4 receptor (MC4R): antagonists of MC4R | | AID | 540295 | | BioAssay type | screening | | Target | melanocortin receptor 4 [Homo sapiens] [gi:119508433] | | PubMed | | | Data Table |  |
|
| 47 | [SID74373446] | Active | | | TRFRET-based cell-based primary high throughput screening assay to identify biased ligands of the melanocortin 4 receptor (MC4R): antagonists of MC4R [AID540295, Type: screening] | melanocortin receptor 4 [Homo sapiens] [gi:119508433] |  View X | Row No. | 47 | | Structure |
| | Substance | | | SID | 74373446 | | CID | 53299545 | | Outcome | Active | | BioAssay | TRFRET-based cell-based primary high throughput screening assay to identify biased ligands of the melanocortin 4 receptor (MC4R): antagonists of MC4R | | AID | 540295 | | BioAssay type | screening | | Target | melanocortin receptor 4 [Homo sapiens] [gi:119508433] | | PubMed | | | Data Table |  |
|
| 48 | [SID124753353] | Active | | | TRFRET-based biochemical primary high throughput screening assay to identify inhibitors of 5-meCpG-binding domain protein 2 (MBD2)-DBD binding to methylated oligonucleotide [AID686964, Type: screening] | Methyl-CpG binding domain protein 2 [Homo sapiens] [gi:21595776] |  View X | Row No. | 48 | | Structure |
| | Substance | | | SID | 124753353 | | CID | 53299545 | | Outcome | Active | | BioAssay | TRFRET-based biochemical primary high throughput screening assay to identify inhibitors of 5-meCpG-binding domain protein 2 (MBD2)-DBD binding to methylated oligonucleotide | | AID | 686964 | | BioAssay type | screening | | Target | Methyl-CpG binding domain protein 2 [Homo sapiens] [gi:21595776] | | PubMed | | | Data Table |  |
|
| 49 | [SID74373446] | Active | | | Image-Based HTS for Selective Agonists for NTR1 [AID493036, Type: screening] | NTSR1 gene product [Homo sapiens] [gi:110611243] |  View X | Row No. | 49 | | Structure |
| | Substance | | | SID | 74373446 | | CID | 53299545 | | Outcome | Active | | BioAssay | Image-Based HTS for Selective Agonists for NTR1 | | AID | 493036 | | BioAssay type | screening | | Target | NTSR1 gene product [Homo sapiens] [gi:110611243] | | PubMed | | | Data Table |  |
|
| 50 | [SID74373446] | Active | | | Image-Based HTS for Selective Agonists for NTR1 [AID493036, Type: screening] | NTSR1 gene product [Homo sapiens] [gi:110611243] |  View X | Row No. | 50 | | Structure |
| | Substance | | | SID | 74373446 | | CID | 53299545 | | Outcome | Active | | BioAssay | Image-Based HTS for Selective Agonists for NTR1 | | AID | 493036 | | BioAssay type | screening | | Target | NTSR1 gene product [Homo sapiens] [gi:110611243] | | PubMed | | | Data Table |  |
|